Global X HealthTech ETF (NASDAQ:HEAL) Sees Significant Decline in Short Interest

Global X HealthTech ETF (NASDAQ:HEAL) saw a significant decline in short interest in December. As of December 31st, there was short interest totaling 7,741 shares, a decline of 57.7% from the December 15th total of 18,284 shares. Currently, 0.6% of the shares of the stock are sold short. Based on an average daily volume of 23,041 shares, the days-to-cover ratio is currently 0.3 days. Based on an average daily volume of 23,041 shares, the days-to-cover ratio is currently 0.3 days. Currently, 0.6% of the shares of the stock are sold short.

Global X HealthTech ETF Stock Performance

Shares of HEAL stock traded up $0.09 during trading hours on Thursday, hitting $30.97. The company had a trading volume of 2,917 shares, compared to its average volume of 14,172. Global X HealthTech ETF has a 12 month low of $24.48 and a 12 month high of $35.73. The firm’s fifty day moving average is $30.43 and its 200 day moving average is $31.35. The firm has a market capitalization of $42.74 million, a price-to-earnings ratio of 42.80 and a beta of 1.13.

Global X HealthTech ETF Announces Dividend

The business also recently disclosed a dividend, which was paid on Wednesday, January 7th. Shareholders of record on Tuesday, December 30th were paid a dividend of $0.0718 per share. The ex-dividend date was Tuesday, December 30th.

Institutional Investors Weigh In On Global X HealthTech ETF

Several institutional investors and hedge funds have recently made changes to their positions in the company. Daiwa Securities Group Inc. bought a new stake in shares of Global X HealthTech ETF in the 3rd quarter worth about $11,239,000. Flow Traders U.S. LLC bought a new stake in Global X HealthTech ETF during the third quarter worth about $368,000. Raymond James Financial Inc. bought a new stake in Global X HealthTech ETF during the third quarter worth about $274,000. Citadel Advisors LLC acquired a new stake in shares of Global X HealthTech ETF during the third quarter worth approximately $216,000. Finally, Banque Cantonale Vaudoise acquired a new stake in shares of Global X HealthTech ETF during the third quarter worth approximately $37,000.

About Global X HealthTech ETF

An ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.